A facility-level self-assessment of Autonomous Pharmacy Framework levels.

Nicholas Goldsmith¹, Mark Sullivan², Sabrina W Cole¹, Gee Mathen³, Nikki Polis⁴, Deepak Sisodiya⁵, Trish Tanner⁶, Jeff Wagner⁷, Allen J Flynn⁸

¹Omnicell, Fort Worth, TX, USA.

²Vanderbilt University Medical Center, Nashville, TN, USA.

³Texas Children's Hospital, Houston, TX, USA.

⁴Methodist Le Bonheur Healthcare, Memphis, TN, USA.

⁵UCLA Health, Los Angeles, CA, USA.

⁶Ballad Health, Johnson City, TN, USA.

⁷Texas Childrens Hospital, Houston, TX, USA.

⁸University of Michigan School of Information and School of Medicine, Ann Arbor, MI, USA.

PubMed DOI

Abstract

PURPOSE: The objective of this study was to understand at what level of the Autonomous Pharmacy Framework facilities are operating, in terms of the current state of data collection and analysis in the medication-use process, and to gather insights about systems integration and automation use. METHODS: The Autonomous Pharmacy Advisory Board, a group of chief pharmacy officers and operational leade…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.